(Q34785781)

English

The pharmacology of cilostazol

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

title

The pharmacology of cilostazol (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Karsten Schrör

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

publication date

1 March 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

published in

Diabetes, Obesity and Metabolism

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

volume

4 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

page(s)

S14-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

cites work

Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.0040S2S14.X

retrieved

21 January 2018

Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.0040S2S14.X

retrieved

21 January 2018

The effect of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on heparin-binding EGF-like growth factor expression in macrophages and vascular smooth muscle cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.0040S2S14.X

retrieved

21 January 2018

Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin II-forming enzymes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.0040S2S14.X

retrieved

21 January 2018

Clinical evaluation on combined administration of oral prostacyclin analogue beraprost and phosphodiesterase inhibitor cilostazol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.0040S2S14.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1463-1326.2002.0040S2S14.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

PubMed publication ID

12180353

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12180353

retrieved

4 August 2017

(Q34785781)

The pharmacology of cilostazol

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)